• 5129 Citations
  • 34 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Eric P Tamm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Tomography Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Pancreas Medicine & Life Sciences
Radiology Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

1 Citation (Scopus)

Dual-energy CT: Lower limits of iodine detection and quantification

Jacobsen, M. C., Cressman, E. N. K., Tamm, E. P., Baluya, D. L., Duan, X., Cody, D., Schellingerhout, D. & Layman, R. R., Jan 1 2019, In : Radiology. 292, 2, p. 414-419 6 p.

Research output: Contribution to journalArticle

Iodine
Limit of Detection
Iohexol
Water
Biomarkers
1 Citation (Scopus)
gemcitabine
Adenocarcinoma
Drug Therapy
130-nm albumin-bound paclitaxel
Confidence Intervals

Is it tumor encasement or arterial dissection/thrombosis? EUS to the rescue!

Cazacu, I. M., Singh, B. S., Tzeng, C-W. D., Tamm, E. P. & Bhutani, M., Jan 1 2019, In : VideoGIE. 4, 1, p. 24-26 3 p.

Research output: Contribution to journalArticle

Dissection
Thrombosis
Neoplasms

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience

Bhutani, M. S., Cazacu, I. M., Luzuriaga Chavez, A. A., Singh, B. S., Wong, F. C. L., Erwin, W. D., Tamm, E. P., Mathew, G. G., Le, D. B., Koay, E. J., Taniguchi, C. M., Minsky, B. D., Pant, S., Tzeng, C. W. D., Koong, A. C., Varadhachary, G. R., Katz, M. H. G., Wolff, R. A., Fogelman, D. R. & Herman, J. M., May 2019, In : VideoGIE. 4, 5, p. 223-225 3 p.

Research output: Contribution to journalArticle

Open Access
Brachytherapy
Pancreatic Neoplasms
Phosphorus
Therapeutics
1 Citation (Scopus)

Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial

Wei, A. C., Ou, F. S., Shi, Q., Carrero, X., O’Reilly, E. M., Meyerhardt, J., Wolff, R. A., Kindler, H. L., Evans, D. B., Deshpande, V., Misdraji, J., Tamm, E., Sahani, D., Moore, M., Newman, E., Merchant, N., Berlin, J., Goff, L. W., Pisters, P. & Posner, M. C., Dec 1 2019, In : Annals of surgical oncology. 26, 13, p. 4489-4497 9 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreaticoduodenectomy
Adenocarcinoma
Confidence Intervals
Survival